Tue, February 28, 2012
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
00 am ET
Wed, February 22, 2012
Tue, February 21, 2012
Mon, February 20, 2012
Sat, February 18, 2012
Fri, February 17, 2012
Thu, February 16, 2012
Wed, February 15, 2012
[ Wed, Feb 15th 2012 ] - Market Wire
Biogen Idec adquiere Stromedix
Tue, February 14, 2012

Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference


//health-fitness.news-articles.net/content/2012/ .. -in-citi-2012-global-health-care-conference.html
Published in Health and Fitness on Tuesday, February 21st 2012 at 6:21 GMT by Market Wire   Print publication without navigation


Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference -- ALISO VIEJO, Calif., Feb. 21, 2012 /PRNewswire/ --

Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference

[ ]

ALISO VIEJO, Calif., Feb. 21, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (Nasdaq: [ AVNR ]) today announced that company management will participate in the Citi 2012 Global Health Care Conference.

  • Citi 2012 Global Health Care Conference
    • The Waldorf Astoria Hotel, New York, NY
    • Wednesday, February 29, 2012
    • 9:00 a.m. ET

A live webcast and 30-day archive of this presentation will be available at [ http://ir.avanir.com ].

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
[ ir@avanir.com ]
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.avanir.com ]


Publication Contributing Sources